Clinical Trial: REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Anal Cancer
Study Type: INTERVENTIONAL
Official Title: REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation
Brief Summary:
To determine the efficacy of reduced elective nodal radiation in anal cancer patients undergoing chemoradiation in reducing toxicity compared to standard nodal irradiation.
Read more